These findings collectively indicate that circCDYL2 enhances the HR repair capabilities in nasopharyngeal carcinoma cells through upregulation of RAD51, thereby promoting cellular survival after radiotherapy. The gene discussed is RAD51; the disease is nasopharyngeal carcinoma.